Alzheimer's disease drug

Alzheimer's disease drug

C022/2472 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.6MB

Downloadable file size: 2.3MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only Not to be shared on social media or embedded in a web page without permission.

Caption: Memantine Alzheimer's disease drug. Box containing tablets of the Alzheimer's disease drug memantine hydrochloride, marketed under the name Memantine Mylan. Memantine helps relieve the symptoms of moderate-to-severe Alzheimer's disease by acting on the glutamatergic system through blocking NMDA-type glutamate receptors in the brain. However, it has been shown to have little effect in mild forms of the disease.

Release details: Model release available. Property release not required.

Keywords: alzheimer'ss disease, alzheimers, antagonist, biochemical, biochemistry, blocker, box, boxed, chemical, chemistry, dementia, drug, glutamatergic system, healthcare, medical, medication, medicine, memantine hydrochloride, memantine mylan, nmda-type glutamate receptor, nurse, one person, packaged, packaging, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prescribed, prescription, psychiatric, psychiatry, psychological, psychology, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.